The Comparative Effectiveness of Natalizumab and Anti-CD20 Monoclonal Antibodies in Relapsing-Remitting Multiple Sclerosis: A Real-World based Study

被引：0

作者：

Zeineddine, Maya ^{[1
,2
]}

Alroughani, Raed ^{[3
]}

Mohamed, Samar Farouk Ahmed ^{[4
]}

Al Mahdawi, Akram ^{[5
]}

Khoury, Samia ^{[6
]}

El Ayoubi, Nabil ^{[6
]}

Inshasi, Jihad ^{[7
,8
]}

Al Khaboori, Jaber ^{[9
]}

Al-Asmi, Abdullah ^{[10
,11
]}

Gouider, Riadh ^{[12
]}

Aljarallah, Salman ^{[13
]}

Al Khawajah, Nuha Marwan ^{[13
]}

Al Malik, Yaser ^{[14
,15
]}

Abulaban, Ahmad ^{[14
,15
]}

Makkawi, Seraj ^{[14
,15
,16
]}

Khojah, Osama ^{[14
,15
,16
]}

El Hajj, Taghrid ^{[17
]}

Massouh, Joelle ^{[18
]}

Alsalamat, Husam ^{[19
]}

Dimassi, Hani ^{[2
]}

al-hajje, Amal ^{[20
,21
]}

Salameh, Pascale ^{[20
,21
,22
,23
]}

Boumediene, Farid ^{[1
]}

Yamout, Bassem I. ^{[18
]}

机构：

[1] Univ Limoges, CHU Limoges, Inserm,Inst Epidemiol & Trop Neurol,Omega Hlth, U1094,IRD U270,EpiMaCT Epidemiol Chron Dis Trop Z, Limoges, France

[2] Lebanese Amer Univ, Sch Pharm, Byblos, Lebanon

[3] Amiri Hosp, Kuwait, Kuwait

[4] Ibn Sina Hosp, Kuwait, Kuwait

[5] Baghdad Med City Teaching Hosp, Baghdad, Iraq

[6] Amer Univ Beirut, Nehme & Therese Tohme Multiple Sclerosis Ctr, Med Ctr, Beirut, Lebanon

[7] Rashid Hosp, MS Dept, Dubai, U Arab Emirates

[8] Dubai Hlth Author, Dubai Med Coll, Dubai, U Arab Emirates

[9] Royal Hosp, Dept Neurol, Muscat, Oman

[10] Sultan Qaboos Univ, Neurol Unit, Dept Med, Coll Med & Hlth Sci, Muscat, Oman

[11] Sultan Qaboos Univ, Sultan Qaboos Univ Hosp, Muscat, Oman

[12] Razi Univ Hosp Mannouba, Clin Invest Ctr Neurosci & Mental Health, Dept Neurol, LR18SP03, Tunsi, Tunisia

[13] Med City, Riyadh, Saudi Arabia

[14] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Jeddah, Saudi Arabia

[15] Minist Natl Guard Hlth Affairs, Dept Neurosci, Jeddah, Saudi Arabia

[16] King Abdullah Int Med Res Ctr, Jeddah, Saudi Arabia

[17] Lebanese Univ, Fac Med Sci, Beirut, Lebanon

[18] Harley St Med Ctr, Neurol Inst, Abu Dhabi, U Arab Emirates

[19] Al Balqa Appl Univ, Fac Med, Al Salt 19117, Jordan

[20] Lebanese Univ, Fac Pharm, Beirut, Lebanon

[21] Natl Inst Publ Hlth Clin Epidemiol & Toxicol INSP, Beirut, Lebanon

[22] Lebanese Amer Univ, Sch Med, Byblos, Lebanon

[23] Univ Nicosia, Sch Med, Dept Primary Care & Populat Hlth, CY-2417 Nicosia, Cyprus

来源：

MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

O096/1296

引用

页码：91 / 92

页数：2

共 50 条

[21] REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
Batista, S.
Nunes, C. C.
Cerqueira, J. J.
Martins Silva, Ana
Correia de Sa, J.
Ferreira, J.
Mendonca, M. T.
Pinheiro, J.
Salgado, V.
Correia, A. S.
Sequeira, J.
Costa, A.
Sousa, L.
NEUROLOGICAL SCIENCES, 2021, 42 (05) : 1995 - 2003
[22] Comparative effectiveness of natalizumab and fingolimod in different subgroups of patients with relapsing-remitting multiple sclerosis
Sharmin, S.
Lefort, M.
Andersen, J.
Horakova, D.
Havrdova, E. K.
Alroughani, R.
Izquierdo, G.
Eichau, S.
Ozakbas, S.
Butzkueven, H.
Patti, F.
Onofrj, M.
Lugaresi, A.
Terzi, M.
Grammond, P.
Grand'Maison, F.
Yamout, B.
Prat, A.
Girard, M.
Duquette, P.
Boz, C.
Trojano, M.
McCombe, P.
Slee, M.
Lechner-Scott, J.
Turkoglu, R.
Sola, P.
Ferraro, D.
Granella, F.
Shaygannejad, V.
Prevost, J.
Skibina, O.
Solaro, C.
Karabudak, R.
Van Wijmeersch, B.
Csepany, T.
Spitaleri, D.
Vucic, S.
Leray, E.
Sorensen, P. S.
Sellebjerg, F.
Magyari, M.
Vukusic, S.
Kalincik, T.
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 786 - 788
[23] REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
S. Batista
C. C. Nunes
J. J. Cerqueira
Ana Martins Silva
J. Correia de Sá
J. Ferreira
M. T. Mendonça
J. Pinheiro
V. Salgado
A. S. Correia
J. Sequeira
A. Costa
L. Sousa
Neurological Sciences, 2021, 42 : 1995 - 2003
[24] Effects of anti-CD20 monoclonal antibody therapy on cerebrospinal fluid B cell subsets in relapsing-remitting multiple sclerosis
El Mahdaoui, S.
Hansen, M. M.
von Essen, M.
Sellebjerg, F.
Christensen, J. Romme
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 840 - 840
[25] Efficacy of natalizumab and fingolimod in relapsing-remitting multiple sclerosis in real world clinical practice
Totaro, R.
Costantino, G.
Bellantonio, P.
Danni, M.
Di Carmine, C.
Fantozzi, R.
Cerqua, R.
Fuiani, A.
Mundi, C.
Ruggieri, S.
Marini, C.
Provinciali, L.
Carolei, A.
MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 267 - 267
[26] Circulating and Cerebrospinal Fluid Monocytes in Relapsing-Remitting Multiple Sclerosis: Implications of Anti-CD20 Therapy
Hansen, Marie Mathilde
El Mahdaoui, Sahla
Hansen, Malene Bredahl
Hvalkof, Victoria
Mahler, Mie Reith
Soendergaard, Helle Bach
Jennum, Poul Jorgen
Sellebjerg, Finn
von Essen, Marina Rode
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 238 - 238
[27] Real-world effectiveness of TYSABRI® (natalizumab) treatment in patients with relapsing remitting multiple sclerosis in Argentina and Chile
Ysrraelit, C.
Caride, A.
Sinay, V.
Rivera Kindel, M.
Halfon, J.
Patrucco, L.
Piedrabuena, R.
Diaz Aragunde, V.
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 979 - 979
[28] Cost effectiveness of glatiramer acetate and natalizumab in relapsing-remitting multiple sclerosis
Stephanie R. Earnshaw
Jonathan Graham
MerriKay Oleen-Burkey
Jane Castelli-Haley
Kenneth Johnson
Applied Health Economics and Health Policy, 2009, 7 (2) : 91 - 108
[29] Real-world disability improvement in patients with relapsing-remitting multiple sclerosis treated with natalizumab in the Tysabri Observational Program
Wiendl, Heinz
Spelman, Tim
Butzkueven, Helmut
Kappos, Ludwig
Trojan, Maria
Su, Ray
Campbell, Nolan
Ho, Pei-Ran
Licata, Stephanie
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (05) : 719 - 728
[30] Cost Effectiveness of Glatiramer Acetate and Natalizumab in Relapsing-Remitting Multiple Sclerosis
Earnshaw, Stephanie
Graham, Jonathan
Oleen-Burkey, MerriKay
Castelli-Haley, Jane
Johnson, Kenneth
APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2009, 7 (02) : 91 - 108

← 1 2 3 4 5 →